Ferrous Gluconate
CAS 299-29-6
Ferrous Gluconate (CAS 299-29-6) is a pharmaceutical compound with 0 bioactivity targets and 164 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Appendicolith | 157 | 483.681 | 10074458 |
| Appendicitis | 157 | 330.574 | 10003011 |
| Cardiogenic shock | 161 | 247.217 | 10007625 |
| Presbyacusis | 73 | 230.971 | 10036626 |
| Reversible airways obstruction | 64 | 221.522 | 10062109 |
| Vital capacity decreased | 62 | 216.181 | 10047582 |
| Pleural fibrosis | 73 | 198.22 | 10035600 |
| Pleural thickening | 64 | 187.482 | 10035616 |
| Sputum culture positive | 62 | 180.52 | 10051612 |
| Stress | 184 | 177.814 | 10042209 |
| Abdominal pain | 422 | 177.552 | 10000081 |
| Ascites | 177 | 176.193 | 10003445 |
| Blood magnesium increased | 63 | 173.471 | 10005655 |
| Bronchial secretion retention | 62 | 172.261 | 10066820 |
| Blood phosphorus increased | 79 | 171.483 | 10050196 |
| Ventricular fibrillation | 116 | 169.265 | 10047290 |
| Deafness neurosensory | 73 | 166.908 | 10011891 |
| Oesophageal spasm | 57 | 158.829 | 10030184 |
| Epigastric discomfort | 71 | 153.807 | 10053155 |
| Abdominal distension | 202 | 145.989 | 10000060 |
| Oesophageal pain | 56 | 144.482 | 10030180 |
| Smear cervix abnormal | 46 | 131.185 | 10041206 |
| Multiple organ dysfunction syndrome | 179 | 122.718 | 10077361 |
| Cyst | 75 | 118.118 | 10011732 |
| Osteopenia | 80 | 113.012 | 10049088 |
| Bone cyst | 45 | 112.978 | 10005952 |
| Upper-airway cough syndrome | 65 | 110.166 | 10070488 |
| Multiple allergies | 65 | 105.254 | 10028164 |
| Osteosclerosis | 46 | 104.407 | 10031298 |
| Eosinophil count increased | 66 | 95.597 | 10014945 |
| Lymphoedema | 60 | 93.795 | 10025282 |
| Obstructive airways disorder | 82 | 91.06 | 10061877 |
| Vomiting | 494 | 89.472 | 10047700 |
| Dry eye | 93 | 85.982 | 10013774 |
| Hyponatraemia | 185 | 81.65 | 10021036 |
| Blood pressure fluctuation | 121 | 78.223 | 10005746 |
| Hypophosphataemia | 62 | 77.68 | 10021058 |
| Blood uric acid increased | 52 | 76.012 | 10005861 |
| C-reactive protein decreased | 30 | 71.193 | 10049220 |
| Skin lesion | 86 | 71.176 | 10040882 |
| Deformity | 48 | 69.957 | 10061619 |
| Myasthenia gravis | 44 | 68.469 | 10028417 |
| Vitamin D deficiency | 54 | 67.496 | 10047626 |
| Urticaria | 190 | 66.404 | 10046735 |
| Pulmonary mass | 68 | 65.963 | 10056342 |
| Nausea | 615 | 65.663 | 10028813 |
| Full blood count abnormal | 80 | 64.089 | 10017412 |
| Blood potassium increased | 66 | 63.831 | 10005725 |
| Alopecia | 21 | 62.482 | 10001760 |
| Hyperhidrosis | 160 | 62.163 | 10020642 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| FERROUS GLUCONATE | 24942 | SU | MTHSPL |
| ferrous gluconate | 24942 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Ferrous Gluconate used for in pharmaceutical contexts?
Ferrous Gluconate (CAS 299-29-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Ferrous Gluconate?
Ferrous Gluconate has 164 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Appendicolith, Appendicitis, Cardiogenic shock, Presbyacusis, Reversible airways obstruction. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Ferrous Gluconate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Ferrous Gluconate with EU status "permitted".
What clinical phase is Ferrous Gluconate in?
No phase 1-4 clinical development badge is rendered for Ferrous Gluconate because the matched compound identifier rows do not contain a max-phase value.